Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Erythroped SF 250mg/5ml oral suspension
0501050H0BDAMAM
|
Erythroped | Erythromycin ethylsuccinate | Infections | 20 |
|
Erythroped PI SF 125mg/5ml oral suspension
0501050H0BDANAL
|
Erythroped | Erythromycin ethylsuccinate | Infections | 17 |
|
Erythroped A 500mg tablets
0501050H0BDAIAE
|
Erythroped | Erythromycin ethylsuccinate | Infections | 7 |
|
Erythroped Forte SF 500mg/5ml oral suspension
0501050H0BDAPAN
|
Erythroped | Erythromycin ethylsuccinate | Infections | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.